Heartburn News and Research RSS Feed - Heartburn News and Research

Heartburn, also know as acid reflux, is a painful and burning sensation in the esophagus, just behind the breastbone usually associated with regurgitation of gastric acid (gastric reflux).
Drugs used to treat acid reflux and ulcers may increase risk of developing kidney stones and CKD

Drugs used to treat acid reflux and ulcers may increase risk of developing kidney stones and CKD

Certain medications commonly used to treat heartburn, acid reflux, and ulcers can have damaging effects on the kidneys. [More]
'Sponge on a string' test could spare people with Barrett's oesophagus from endoscopies

'Sponge on a string' test could spare people with Barrett's oesophagus from endoscopies

Cancer Research UK-funded scientists have discovered that a 'sponge on a string' pill test can identify which people with a condition called Barrett's oesophagus have a low risk of developing oesophageal cancer - sparing them uncomfortable endoscopies. [More]
Certain medications can have important effect on success of dental implants, research shows

Certain medications can have important effect on success of dental implants, research shows

Each year, about 500,000 North Americans get dental implants. If you are one of them, and are preparing to have an implant, it might be a good idea to start taking beta blockers, medication that controls high blood pressure, for a while. And to stop taking heartburn pills. [More]
CPAP therapy may help improve nighttime acid reflux symptoms in patients with OSA

CPAP therapy may help improve nighttime acid reflux symptoms in patients with OSA

A new study suggests that CPAP therapy may help improve the symptoms of nocturnal gastroesophageal reflux in patients with obstructive sleep apnea. [More]
Chronic cough different than cough from cold, says allergist

Chronic cough different than cough from cold, says allergist

There's been a lot of talk about politicians and coughs lately. And we've all seen public figures struggle with it. [More]
New study uses evolutionary theory to predict cancer risk in patients with Barrett's esophagus

New study uses evolutionary theory to predict cancer risk in patients with Barrett's esophagus

A disorder known as Barrett's esophagus (BE) affects some 200,000 Americans each year. The condition, which is caused by stomach acid damaging the lining of the esophagus, can lead to the development of a serious, potentially fatal cancer of epithelial tissue, known as esophageal adenocarcinoma. [More]
Testing lesions in food pipe could provide early and accurate diagnosis of oesophageal cancer

Testing lesions in food pipe could provide early and accurate diagnosis of oesophageal cancer

Genetically analysing lesions in the food pipe could provide an early and accurate test for oesophageal cancer, according to research led by Queen Mary University of London, Academic Medical Center in Amsterdam and Arizona State University. [More]
New research explores women’s perspective about medication use during pregnancy

New research explores women’s perspective about medication use during pregnancy

Pregnant women overestimate the risks of taking over the counter and prescribed medication - according to new research from the University of East Anglia. [More]
Combination of COX-2-selective NSAID with PPI can reduce risk of stomach, intestinal ulcers

Combination of COX-2-selective NSAID with PPI can reduce risk of stomach, intestinal ulcers

Non-steroidal anti-inflammatory drugs (NSAIDs)—including ibuprofen, diclofenac, naproxen and others—are commonly used pain medications that are generally safe but may increase the risk of developing stomach and intestinal ulcers. [More]
Chronic use of antacid drugs may speed up aging of blood vessels

Chronic use of antacid drugs may speed up aging of blood vessels

Chronic use of some drugs for heartburn and gastroesophageal reflux (GERD) speeds up the aging of blood vessels, according to a published paper in Circulation Research, an American Heart Association journal. [More]
Genetic modification in esophagus can lead to esophageal cancer

Genetic modification in esophagus can lead to esophageal cancer

A genetic modification in the mucous membrane of the esophagus, the Barrett esophagus, can lead to esophageal cancer. If certain biomarkers are contained in these tissue alterations, so-called miDNA, these are extremely short DNA strands, it could be an indication that this preliminary stage of esophageal cancer indeed leads to cancer. [More]
Drugs approved for various conditions also have antibiotic properties

Drugs approved for various conditions also have antibiotic properties

A number of drugs already approved to treat parasitic infections, cancers, infertility and other conditions also show promise as antibiotic agents against staph and tuberculosis infections, according to a new study by University of Illinois chemists and collaborators. Because these agents act against multiple targets within the bacteria, it may be harder for bacteria to develop resistance. [More]
New guidelines may help reduce medication use among seniors

New guidelines may help reduce medication use among seniors

We're not getting any younger. According to the Administration for Community Living, by 2060, there will be about 98 million older persons in the United States — more than twice their number in 2013. [More]
People who experience persistent heartburn despite over-the-counter treatments need to check with their doctors

People who experience persistent heartburn despite over-the-counter treatments need to check with their doctors

If Thanksgiving makes you wince at the thought of impending heartburn pain, you are probably not alone. But if you experience heartburn more than twice a week despite over-the-counter treatments, a Jefferson expert wants you to check with your doctor. Gastroesophageal Reflux Disease (GERD) Awareness Week is observed each year during the week of Thanksgiving, a fitting time as Americans prepare to indulge in the holiday season. [More]
Stony Brook Medicine expert shares tips to minimize heartburn during holiday season

Stony Brook Medicine expert shares tips to minimize heartburn during holiday season

The holiday season is upon us and most days and nights will be filled with delicious festivities! However, with millions of Americans suffering from heartburn, fear may set in when anticipating these celebrations. [More]
EndoGastric Solutions announces assignment of relative value units for new CPT code covering TIF procedure

EndoGastric Solutions announces assignment of relative value units for new CPT code covering TIF procedure

EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced the Federal Register has posted coding and payment information specific to the new Current Procedural Terminology (CPT)® code covering the Transoral Incisionless Fundoplication (TIF®) procedure. [More]
Common heartburn, acid reflux drugs may increase risk for developing kidney disease

Common heartburn, acid reflux drugs may increase risk for developing kidney disease

Certain medications commonly used to treat heartburn and acid reflux may have damaging effects on the kidneys, according to two studies that will be presented at ASN Kidney Week 2015 November 3–8 at the San Diego Convention Center in San Diego, CA. The drugs, proton pump inhibitors (PPIs), are among the top 10 class of prescribed medications in the United States. [More]
Mercy open new Endoscopy Suite to promote and practice gastrointestinal health

Mercy open new Endoscopy Suite to promote and practice gastrointestinal health

Mercy Medical Center has announced the opening of a new, state-of-the-art Endoscopy Suite to promote and practice gastrointestinal health. The unique, high-tech suite is located on the 2nd floor of Mercy's Mary Catherine Bunting Center at 345 St. Paul Place. Bunting Endoscopy will be under the direction of Dr. Paul J. Thuluvath, Medical Director of The Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy. [More]

Camber Pharmaceuticals releases generic version of Nexium (Esomeprazole) capsules

Camber Pharmaceuticals is pleased to announce that it has launched Esomeprazole Magnesium Delayed-Release Capsules, 20 mg and 40 mg, which is the generic version of Nexium (Esomeprazole) capsules from AstraZeneca Pharmaceuticals. The product is indicated for the treatment of heartburn, gastroesophageal reflux disease (GERD), stomach ulcers, and for a damaged esophagus. [More]
Women who conceive babies through IVF at increased risk of experiencing GORD

Women who conceive babies through IVF at increased risk of experiencing GORD

Women who give birth to babies conceived by in-vitro fertilisation (IVF) are at increased risk of experiencing long-term symptoms of gastro-oesophageal reflux disease (GORD), according to the results of a study published in the UEG Journal. [More]
Advertisement
Advertisement